Skip to main content

Lexaria Bioscience Corp.

LEXX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001348362

No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.

Members of Congress who traded LEXX

No member of Congress has reported a trade in Lexaria Bioscience Corp. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.